A new trial finds that cetuximab outperforms durvalumab as a second-line treatment in patients who cannot tolerate cisplatin.

Vaccination of 27- to 45-year-olds against HPV is less cost-effective than vaccination of younger persons (aged 9 to 26 years).

A new study provides good evidence that the human papillomavirus (HPV) vaccine may be achieving its goal of slashing rates of ...

Dr. Carrie Sopata, a gynecologist at UVA Health, said women can opt for the new procedure to avoid a speculum exam.

Researchers observed a “steep decline” in cervical cancer deaths between 2016 and 2021 among US women younger than 25 years of age.

Robert F. Kennedy Jr., President-elect Donald Trump’s pick to oversee the nation’s health system, worries the medical ...

Delve into the expanding and diverse field of cancer vaccines with various approaches exploiting the immune system to fight ...

Cervical cancer, considered a “highly preventable” disease, has long been declining in the United States — but it’s now on ...

Bolivia has taken a critical step towards strengthening its cancer control system by hosting an imPACT Review mission led by the IAEA, the World Health Organization (WHO), and the International Agency ...

Human papillomavirus (HPV) is a common viral infection typically transmitted through intimate contact, primarily during ...

In the vibrant streets of Nairobi, a silent health crisis is unfolding, casting a shadow over the lives of gay, bisexual, and ...

Gen Z is largely ready for an inter-generational truce to take place. And now for the hard-hitting question: Are you?